Dare Bioscience, Inc. Debt Conversion, Converted Instrument, Rate
Dare Bioscience, Inc. (DARE) reported Debt Conversion, Converted Instrument, Rate of 77.50% for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2014-08-12
- Dare Bioscience, Inc. debt conversion, converted instrument, rate for the quarter ending 2014-03-31 was 77.50%.
| Period end | Debt Conversion, Converted Instrument, Rate 3 month | Debt Conversion, Converted Instrument, Rate 6 month |
|---|---|---|
| 2014-06-30 | 77.50% 10-Q · filed 2014-08-12 | |
| 2014-03-31 | 77.50% 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |